Patents by Inventor Robert Jonathan Cain

Robert Jonathan Cain has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11925790
    Abstract: Processes and devices provide parenteral delivery of therapeutic fluids, in particular high-viscosity therapeutic fluids (e.g., protein therapeutics), by a chemical reaction that generates a gas. A device may include a first actuation chamber containing a first reagent, a second reaction chamber containing a second reagent, and a third therapeutic fluid chamber containing the therapeutic fluid. In a loaded configuration, a plunger separates the first chamber from the second chamber. In a delivery configuration, the plunger allows the first reagent from the first chamber to communicate and react with the second reagent from the second chamber. The generated gas acts upon a plunger to deliver the therapeutic fluid from the third chamber.
    Type: Grant
    Filed: February 9, 2018
    Date of Patent: March 12, 2024
    Assignee: Eli Lilly and Company
    Inventors: William Godwin Atterbury, Corrie Jo Bennison, Robert Jonathan Cain, Michael Funk Chiappetta, Jeffrey Leclair Ellis, David Arthur Holley, Mark Lafever, Beverly Ann Piatt, John Paul Tallarico
  • Publication number: 20200030537
    Abstract: Processes and devices are disclosed for parenteral delivery of therapeutic fluids, in particular high-viscosity therapeutic fluids (e.g., protein therapeutics), by a chemical reaction that generates a gas. The device may include a first actuation chamber containing a first reagent, a second reaction chamber containing a second reagent, and a third therapeutic fluid chamber containing the therapeutic fluid. In a loaded configuration, a plunger separates the first chamber from the second chamber. In a delivery configuration, the plunger allows the first reagent from the first chamber to communicate and react with the second reagent from the second chamber. The generated gas acts upon a plunger to deliver the therapeutic fluid from the third chamber.
    Type: Application
    Filed: February 9, 2018
    Publication date: January 30, 2020
    Inventors: William Godwin ATTERBURY, Corrie Jo BENNISON, Robert Jonathan CAIN, Michael Funk CHIAPPETTA, Jeffrey LeClair ELLIS, David Arthur HOLLEY, Mark LAFEVER, Beverly Ann PIATT, John Paul TALLARICO
  • Patent number: 10272175
    Abstract: There is provided a composition comprising covalently linked segments of for example, polycaprolactone and polyethylene glycol that are linked by a cross-linker. Such a composition foams in the presence of a catalyst and a solution containing an oxygen forming chemical like hydrogen peroxide. The foamed composition retains oxygen for delivery to, for example, a wound, where it aids in healing.
    Type: Grant
    Filed: November 26, 2014
    Date of Patent: April 30, 2019
    Assignee: Avent, Inc.
    Inventors: Brian J. Cuevas, Sophie Truc Lam, Nathan G. Bonn-Savage, Ramanathan S. Lalgudi, Melissa S. Roshon, Robert Jonathan Cain
  • Publication number: 20160279285
    Abstract: There is provided a composition comprising covalently linked segments of for example, polycaprolactone and polyethylene glycol that are linked by a cross-linker. Such a composition foams in the presence of a catalyst and a solution containing an oxygen forming chemical like hydrogen peroxide. The foamed composition retains oxygen for delivery to, for example, a wound, where it aids in healing.
    Type: Application
    Filed: November 26, 2014
    Publication date: September 29, 2016
    Inventors: Brian J. Cuevas, Sophie Truc Lam, Nathan G. Bonn-Savage, Ramanathan S. Lalgudi, Melissa S. Roshon, Robert Jonathan Cain